Monday, June 17, 2013

• Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira PharmaceuticalsPR Newswire (Mon, Jun 17)

Thursday, June 13, 2013

• KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements andEDGAR Online (Thu, Jun 13)

Tuesday, June 11, 2013

• Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)at TheStreet (Tue, Jun 11)

Friday, June 7, 2013

• Biotech Stock Mailbag: 2013 Clinical Trials Calendarat TheStreet (Fri, Jun 7)

Tuesday, June 4, 2013

• Solid Showing At WCN Conference For Keryx: Catalysts Still To Comeat Seeking Alpha (Tue, Jun 4)
• KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial SEDGAR Online (Tue, Jun 4)
• Clovis Among Top Small-Cap Biotech Picks By Legendary Fund Managers In Q1/2013at Seeking Alpha (Tue, Jun 4)

Monday, June 3, 2013

• Keryx announces positive Zerenex Phase 3 datatheflyonthewall.com (Mon, Jun 3)
• Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of NephrologyPR Newswire (Mon, Jun 3)

Thursday, May 30, 2013

• Here's What This $42 Billion Hedge Fund Company Has Been Buyingat Motley Fool (Thu, May 30)
• Keryx: Attractive In Front Of Catalyst-Rich Second Halfat Seeking Alpha (Thu, May 30)
• 5 Best Biotechs of 2013at Motley Fool (Thu, May 30)

Wednesday, May 29, 2013

• 4 Stocks Under $10 Making Big Movesat TheStreet (Wed, May 29)

Tuesday, May 28, 2013

• BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Marketat Seeking Alpha (Tue, May 28)

Friday, May 24, 2013

• A Review Of Upcoming Catalysts For Kidney Disease Biotech Players In 2013at Seeking Alpha (Fri, May 24)

Wednesday, May 22, 2013

• Biotech Investing for Beginnersat Motley Fool (Wed, May 22)

Tuesday, May 21, 2013

• Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)at TheStreet (Tue, May 21)
• Rockwell Medical Run-Up Trade Follows Financingat TheStreet (Tue, May 21)

Monday, May 20, 2013

• Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trialsat Motley Fool (Mon, May 20)

Sunday, May 19, 2013

• Is Keryx Biopharmaceuticals Burning Too Much Cash?at Motley Fool (Sun, May 19)

Add KERX News to My Yahoo!